Literature DB >> 1649603

Proteolytic fragmentation of tetanus toxin by subcellular fractions of JY, a B lymphoblastoid cell line.

A Reboul1, J Arvieux, J F Wright, M G Colomb.   

Abstract

Proteolysis of 125I-labelled tetanus toxin by subcellular fractions from an Epstein-Barr-virus-transformed B lymphoblastoid cell line, JY, was investigated. Fractions enriched in lysosomes and plasma membranes cleaved the toxin molecule at several sites, with a pH optimum of 5.5. N-Terminal sequence analysis of Mr-81,000, -45,000 and -35,000 proteolytic fragments indicated cleavage of the Asp-460-Leu-461, Asp-872-Glu-873 and Ile-1013-Thr-1014 peptide bonds, all sites located within the heavy chain of the toxin molecule. Additional sites near the C-terminus of the heavy chain, giving rise to low-Mr peptides, were implicated. The toxin light chain was more resistant to proteolysis. A similar pattern of fragmentation was observed with tetanus toxin biosynthetically radiolabelled with 14C-labelled amino acids, showing that the proteolysis was not an artifact caused by iodination. The proteolytic activity was inhibited by the serine proteinase inhibitor di-isopropyl phosphorofluoridate, thiol-blocking proteinase inhibitors N-ethylmaleimide and iodoacetamide, and by EDTA. These results represent a preliminary characterization of the processing in vitro of tetanus toxin by an antigen-presenting cell line.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649603      PMCID: PMC1151189          DOI: 10.1042/bj2770047

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Delineation of several DR-restricted tetanus toxin T cell epitopes.

Authors:  S Demotz; A Lanzavecchia; U Eisel; H Niemann; C Widmann; G Corradin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

3.  The complete nucleotide sequence of tetanus toxin.

Authors:  N F Fairweather; V A Lyness
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

Review 4.  Intracellular proteases.

Authors:  J S Bond; P E Butler
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  The tetanus toxin light chain inhibits exocytosis.

Authors:  G Ahnert-Hilger; U Weller; M E Dauzenroth; E Habermann; M Gratzl
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

6.  Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

Authors:  P Matsudaira
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

7.  Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.

Authors:  K Ziegler; E R Unanue
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Affinity chromatographic purification and characterization of two iodinated tetanus toxin fractions exhibiting different binding properties.

Authors:  P Lazarovici; J L Tayot; E Yavin
Journal:  Toxicon       Date:  1984       Impact factor: 3.033

9.  Analytical subcellular fractionation of cultivated mouse resident peritoneal macrophages.

Authors:  C Darte; H Beaufay
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  2 in total

1.  The structure of the tetanus toxin reveals pH-mediated domain dynamics.

Authors:  Geoffrey Masuyer; Julian Conrad; Pål Stenmark
Journal:  EMBO Rep       Date:  2017-06-23       Impact factor: 8.807

2.  Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes.

Authors:  I Kerblat; S Tongiani-Dahshan; C Aude-Garcia; M Villiers; C Drouet; P N Marche
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.